Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mohty, Mohamad  [Clear All Filters]
2018
Lee, C.J., Labopin, M., Beelen, D., Finke, J., Blaise, D., Ganser, A., Itälä-Remes, M., Chevallier, P., Labussière-Wallet, H., Maertens, J., et al. (2018). Comparative Outcomes of Myeloablative and Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Therapy-Related Acute Myeloid Leukemia with Prior Solid Tumor: a report from the ALWP of the EBMT.Am J Hematol.
Shimoni, A., Labopin, M., Lorentino, F., van Lint, M.Teresa, Koc, Y., Gulbas, Z., Tischer, J., Bruno, B., Blaise, D., Pioltelli, P., et al. (2018). Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.Leukemia.
Gilleece, M.H., Labopin, M., Yakoub-Agha, I., Volin, L., Socié, G., Ljungman, P., Huynh, A., Deconinck, E., Wu, D., Bourhis, J.Henri, et al. (2018). Measurable residual disease, conditioning regimen intensity and age predict outcome of allogeneic hematopoietic cell transplantation for acute myeloid leukemia in first remission: a registry analysis of 2292 patients by the Acute Leukemia Working Party Eu.Am J Hematol.
Belkacemi, Y., Labopin, M., Giebel, S., Gorin, N.Claude, Loganadane, G., Miszczyk, L., Michallet, M., Socié, G., Schaap, N.Pm, Cornelissen, J.J., et al. (2018). Single Dose Daily Fractionated Is Not Inferior To Twice A Day Fractionated Total Body Irradiation Prior To Allogeneic Stem Cell Transplantation For Acute Leukemia: A Useful Practice Simplification Resulting From The Sarasin Study.Int J Radiat Oncol Biol Phys.
Canaani, J., Beohou, E., Labopin, M., Ghavamzadeh, A., Beelen, D., Hamladji, R.-M., Niederwieser, D., Volin, L., Markiewicz, M., Arnold, R., et al. (2018). Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukemia. An ALWP/EBMT analysis.J Intern Med.
2015
D'Aveni, M., Rossignol, J., Coman, T., Sivakumaran, S., Henderson, S., Manzo, T., Sousa, P.Santos E., Bruneau, J., Fouquet, G., Zavala, F., et al. (2015). G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease.Sci Transl Med7, 281ra42.
Shah, N., Callander, N., Ganguly, S., Gul, Z., Hamadani, M., Costa, L., Sengsayadeth, S., Abidi, M., Hari, P., Mohty, M., et al. (2015). Hematopoietic Stem Cell Transplantation for Multiple Myeloma: Guidelines from the ASBMT.Biol Blood Marrow Transplant.
Beaussant, Y., Daguindau, E., Pugin, A., Mohty, M., Avet-Loiseau, H., Roos-Weil, D., Michallet, M., Chevalier, P., Raus, N., El-Cheikh, J., et al. (2015). Hematopoietic stem cell transplantation in multiple myeloma. A retrospective study of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Biol Blood Marrow Transplant.
Brands-Nijenhuis, A.V.M., Labopin, M., Schouten, H.C., Volin, L., Socié, G., Cornelissen, J.J., Huynh, A., Ljungman, P., Malard, F., Esteve, J., et al. (2015). Monosomal karyotype as an adverse prognostic factor in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem-cell transplantation in first complete remission. A retrospective survey on behalf of the ALWP of EBMT.Haematologica.
Poire, X., Labopin, M., Cornelissen, J.J., Volin, L., Espiga, C.Richard, J Veelken, H., Milpied, N., Cahn, J.-Y., Yacoub-Agha, I., van Imhoff, G.W., et al. (2015). Outcome of conditioning intensity in acute myeloid leukemia with monosomal karyotype in patients over 45 year-old: A study from the Acute Leukemia Working Party (ALWP) of the European group of Blood and Marrow Transplantation (EBMT).Am J Hematol.
Peric, Z., Cahu, X., Malard, F., Brissot, E., Chevallier, P., Guillaume, T., Gregoire, M., Gaugler, B., and Mohty, M. (2015). Peripheral blood plasmacytoid dendritic cells at day 100 can predict outcome after allogeneic stem cell transplantation.Biol Blood Marrow Transplant.
Li, Z., Mewawalla, P., Stratton, P., Yong, A.S.M., Shaw, B.E., Hashmi, S., Jagasia, M., Mohty, M., Majhail, N.S., Savani, B.N., et al. (2015). Sexual health in hematopoietic stem cell transplant recipients.Cancer.
2014
Touzeau, C., Leux, C., Bouabdallah, R., Roussel, M., Delarue, R., Bouabdallah, K., Thieblemont, C., Cacheux, V., Cartron, G., Compain, L., et al. (2014). Autologous stem cell transplantation in mantle cell lymphoma: a report from the SFGM-TC.Ann Hematol93, 233-42.
Shem-Tov, N., Labopin, M., Moukhtari, L., Ciceri, F., Esteve, J., Giebel, S., Gorin, N.-C., Schmid, C., Shimoni, A., Nagler, A., et al. (2014). Chemotherapy Dose Adjustment for Obese Patients Undergoing Hematopoietic Stem Cell Transplantation: A Survey on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Oncologist.
Le Bourgeois, A., Labopin, M., Guillaume, T., Delaunay, J., Foucher, Y., Tessoulin, B., Malard, F., Ayari, S., Peterlin, P., Derenne, S., et al. (2014). HHV-6 reactivation before engraftment is strongly predictive of graft failure after double umbilical cord blood allogeneic stem cell transplantation in adults.Exp Hematol.
Malard, F., and Mohty, M. (2014). New Insight for the Diagnosis of Gastrointestinal Acute Graft-versus-Host Disease.Mediators Inflamm2014, 701013.
Chevallier, P., Labopin, M., Socié, G., Tabrizi, R., Furst, S., Lioure, B., Guillaume, T., Delaunay, J., de la Tour, R.Peffault, Vigouroux, S., et al. (2014). Results from a clofarabine-busulfan containing reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase II prospective CLORIC trial.Haematologica.
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.

Pages